Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Atrys Health

Biotech & Life Sciences · Madrid, Spain · Founded 2007 · IPO 2016 Thoroughbred

Biomedical company dedicated to provide diagnostic services and excelence medical treatments

Valuation
$504M
Market cap · May/2026
Revenue
$155M
Latest reported FY
EBITDA
$30M
Latest reported FY

Ownership

Who owns Atrys Health

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (May/2026). Percentages are indicative.

24.7% EXCELSIOR TIMES

Some investors are hidden on this public profile. “Other / undisclosed” is the 75.2% not attributed to a named shareholder. See the full cap table on Dealroom →

Global footprint

Where Atrys Health has talent and traffic

Workforce by country
7 countries with
team presence
🇪🇸 Spain70.8%
🇨🇱 Chile11.2%
🇵🇹 Portugal8.5%
🇧🇷 Brazil4%
🇨🇴 Colombia3.9%
Top 5 of 7 shown
Web traffic by country
17K monthly visits
across markets
🇨🇴 Colombia108.2%
🇪🇸 Spain32.4%
🇺🇸 United States6.5%
🇨🇱 Chile3.5%
🇬🇧 United Kingdom3.5%
Top 5 markets shown

Talent graph

The shape of Atrys Health's talent

Dealroom maps Atrys Health's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

29 standout operatorsDealroom-flagged across the org
4 AI specialistspinpointed by name
260 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Atrys Health's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

Atrys Health's 8 investments and acquisitions.

Every disclosed deal where Atrys Health appeared as a backer or acquirer, 2018–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

8 deals across Atrys Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Atrys Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        8 of 8 deals

        Market sentiment

        What the market is saying about Atrys Health

        An AI-synthesized read of the highest-engagement posts about Atrys Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Atrys Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.